Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


AstraZeneca PLC 

15 Stanhope Gate

London  England  W1K 1LN  United Kingdom
Phone: 44-20-7304-5000 Fax: 44-20-7304-5151


 Company News
DrugDev And AstraZeneca PLC (AZN) To Host Educational Case Study Webinar, “S.O.S. – Best Practices For Finding, Engaging And Activating Investigators On A Rescue Study,” October 21, 2014 10/17/2014 11:07:41 AM
AstraZeneca PLC (AZN) Strengthens Partnership With The University of Cambridge 10/16/2014 6:06:00 AM
AstraZeneca PLC (AZN) Launches Fit2Me™, A Free Customized Diet And Lifestyle Support Program For People With Type 2 Diabetes 10/15/2014 1:37:44 PM
AstraZeneca PLC (AZN) Holds Its Breath As European Regulators Mull Cancer Drug Fate 10/15/2014 6:34:25 AM
Analysts Still See AstraZeneca PLC (AZN) As Viable Takeover Target 10/15/2014 6:19:02 AM
Sanofi (SAN.PA) Looks To Rival AstraZeneca PLC (AZN) For New UK & Ireland Head 10/13/2014 6:25:09 AM
AstraZeneca PLC (AZN) Completely Cuts Ties With Targacept, Inc. (TRGT) 10/10/2014 5:59:42 AM
Charles River Laboratories (Massachusetts)’s Early Drug Discovery Collaboration With AstraZeneca PLC (AZN) Delivers Respiratory Candidate Drug 10/7/2014 10:18:58 AM
AstraZeneca PLC (AZN) Deploys Decision Lens For Future Drug Screening And Selection 10/6/2014 11:20:36 AM
AstraZeneca PLC (AZN) Release: BRILINTA Preferred Over Clopidogrel In 2014 American Heart Association/American College of Cardiology Guideline For The Management Of Non–ST-Elevation Acute Coronary Syndromes 10/6/2014 10:36:49 AM